Company intelligence / Profile preview

Shen Xia

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Shen Xia (Shanghai Shenxia Biotechnology) is a specialized biotechnology company focused on providing advanced genomics and bioinformatics services. The company leverages high-throughput sequencing technologies and proprietary statistical methods to support precision medicine, agricultural genomics, and pharmaceutical research. Its core business includes multi-omics data analysis, genetic risk assessment, and the development of customized bioinformatics pipelines for academic and industrial clients. By integrating complex biological data with sophisticated statistical modeling, Shen Xia aims to accelerate the discovery of genetic markers and therapeutic targets.

Industry: Drug Discovery Services

Beyond the preview

Go deeper on Shen Xia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shen Xia.

Explore the full profile